Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma - A Phase Ib Clinical Study

NCT03293784 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT03293784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03293784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma - A Phase Ib Clinical Study
Lead sponsor
Institut Claudius Regaud
Phase
Phase 1
Overall status
Completed
Start date
October 16, 2017
Completion date
August 10, 2023
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma